Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/23/2025

Clinical Use of Prazosin

Therapeutic Applications

  • The American College of Cardiology recommends prazosin for the treatment of hypertension and benign prostatic hyperplasia due to its selective alpha-1 blockade 1
  • Prazosin is also used to treat PTSD-associated nightmares due to its effects on alpha-1 receptors in the central nervous system 2

Important Considerations

  • The American Academy of Sleep Medicine and other guideline societies warn of the first-dose phenomenon, where prazosin can cause significant orthostatic hypotension, especially after the initial dose, and recommend dosing typically starts low (1 mg at bedtime) with gradual titration to minimize orthostatic effects, particularly in elderly patients or those on concurrent antihypertensive medications 3

Prazosin Clinical Applications and Safety

Introduction to Prazosin

  • Prazosin remains widely available for clinical use, prescribed for hypertension, benign prostatic hyperplasia, and PTSD-associated nightmares, as reported by the American Academy of Sleep Medicine 4, 5

Current Clinical Applications

  • The American Academy of Sleep Medicine recognizes prazosin as a first-choice pharmacologic therapy for nightmare disorder, despite recent contradictory evidence requiring a downgraded recommendation 6, 7

Medication Comparison and Safety

  • Drotrecogin alfa (activated) was withdrawn from the market due to lack of efficacy and potential harm from bleeding, as opposed to prazosin which remains available 8

REFERENCES

2

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

3

Prazosin-Induced Hypotension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

5

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

6

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

7

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018